Feasibility of a Smartphone Kiosk intervention to increase HPV vaccination

智能手机亭干预增加 HPV 疫苗接种的可行性

• 批准号: 8904103
• 负责人: Suellen Hopfer
• 金额: $ 22.3万
• 依托单位: REAL PREVENTION, LLC
• 依托单位国家: 美国
• 财政年份: 2015
• 资助国家: 美国
• 起止时间: 2015-04-27 至 2016-03-31
• 项目状态: 已结题
• 来源: https://reporter.nih.gov/project-details/8904103
• 关键词: Accounting; Address; Adult; African American; Awareness; Car Phone; Caring; Cellular Phone; Cervical; Client; Clinic; Code; Communication; Development; Development Plans; Evaluation; Goals; Health; Health Promotion; Healthcare; Human Papilloma Virus Vaccination; Human Papilloma Virus Vaccine; Human Papillomavirus; Human papilloma virus infection; Hybrids; Immunization; Incidence; Infection prevention; Intervention; Knowledge; Latina; Left; Link; Low income; Malignant Neoplasms; Marketing; Minority; Morbidity - disease rate; Motivation; Online Systems; Operating Rooms; Patients; Phase; Population; Prevalence; Prevention; Preventive; Preventive Intervention; Process; Provider; Randomized Controlled Trials; Research; Research Design; Resistance; Screening for cancer; Series; Services; Sexually Transmitted Diseases; Small Business Innovation Research Grant; System; Target Populations; Technology; Testing; Text; Uninsured; Vaccinated; Vaccination; Vaccines; Woman; Women' s Health; Writing; age group; base; cancer risk; commercialization; cost; design; discount; evidence base; follow-up; high risk; innovative technologies; interest; malignant oropharynx neoplasm; mortality; public health relevance; response; socioeconomics; uptake; usability; vaccination strategy; web site; young adult

 DESCRIPTION (provided by applicant): REAL Prevention (RP) is a LLC dedicated to commercializing innovative technologies for delivering evidence-based health promotion practices. RP's communication expertise in designing culturally-grounded prevention interventions using narrative strategies results in effective health messages to engage low knowledge, low awareness and resistant audiences. In partnership with St. Andrew Development (StA) and Planned Parenthood (PP), RP will assess the feasibility of a Smartphone kiosk intervention promoting HPV immunization to Planned Parenthood (PP) clients as part of a Phase I SBIR. HPV infection is the second most costly sexually transmitted infection in the U.S. accounting for HPV morbidity and linked cervical, anogenital, and oropharyngeal cancers. Vaccination for HPV has stagnated in the U.S., remaining lower than 10 percent in the PP population. Given the demonstrated benefit to vaccinating and the low level of awareness that serves as one of the primary barriers, it is important to identify new channels for communicating effective vaccine messages. This study will allow PP, which makes the vaccine available to uninsured patients at no cost and to the insured at a discounted cost, to harness StA's hybrid kiosk, text message, and mobile website technology to overcome vaccination barriers and reduce cancer risk. Key attributes of the unique Smartphone kiosk product that promises to revolutionize the prevention field are: (1) narrative (story-telling form) video messages delivered on kiosks that engage the audience and promote initial vaccination and (2) timely and personalized kiosk-driven text and mobile website messages to insure follow up and completion of the three-series vaccination through personalized vaccine reminder messages after the patients leave the clinic. The use of kiosk messages reinforced by text and web-based messages promises to significantly increase HPV vaccine initiation and series completion thereby, reducing HPV infection. Messages for this system will be based on formative research and piloted tested before being subjected to an independent usability test. Scalability and widespread dissemination of the Smartphone kiosk product is structurally built into the design of the study once feasibility is tested because PP waiting rooms operating similarly in every state utilize kiosk check-in and close to 100 percent of PP clients use mobile phones with a majority being Smartphone users. Scalability and efficacy will be tested in Phase II in a national randomized controlled trial. PP expresses enthusiasm about national distribution and StA will extend the reach of this prevention product to other existing clients serving women's health. The commercialization potential of RP's intervention kiosk Smartphone application is great with the PP and this extended market.

 描述（由申请人提供）：真实的Prevention（RP）是一家致力于将创新技术商业化的有限责任公司，用于提供基于证据的健康促进实践。RP在使用叙事策略设计基于文化的预防干预措施方面的传播专业知识导致了有效的健康信息，以吸引知识不足，认识不足和抵制的受众。与圣安德鲁发展（StA）和计划生育（PP）合作，RP将评估智能手机亭干预的可行性，促进HPV免疫接种计划生育（PP）客户作为第一阶段SBIR的一部分。HPV感染是美国第二大最昂贵的性传播感染，占HPV发病率和相关的宫颈癌，肛门生殖器癌和口咽癌。HPV疫苗接种在美国停滞不前，在PP人口中仍低于10%。鉴于接种疫苗的好处已得到证实，而认识水平低是主要障碍之一，因此必须确定传播有效疫苗信息的新渠道。这项研究将使PP能够利用StA的混合亭，短信和移动的网站技术来克服疫苗接种障碍并降低癌症风险。独特的智能手机亭产品的关键属性，承诺革命性的预防领域是：（1）叙述性（讲故事的形式）在信息亭上传递的视频信息，吸引观众并促进初次接种，以及（2）及时和个性化的信息亭驱动的文本和移动的网站信息，以确保跟进和完成三个-在患者离开诊所后，通过个性化的疫苗提醒信息进行系列接种。通过文本和基于网络的消息加强的信息亭消息的使用有望显着增加HPV疫苗的启动和系列完成，从而减少HPV感染。该系统的消息将基于形成性研究，并在进行独立可用性测试之前进行试点测试。一旦对可行性进行了测试，智能手机自助服务亭产品的可扩展性和广泛传播就在结构上纳入了研究设计，因为每个州的PP等候室都使用自助服务亭办理登机手续，接近100%的PP客户使用移动的电话，其中大多数是智能手机用户。可扩展性和有效性将在II期国家随机对照试验中进行测试。人民党对在全国范围内分发表示热情，卫生署将把这一预防产品的范围扩大到为妇女健康服务的其他现有客户。RP的干预亭智能手机应用程序在PP和这个扩展市场上的商业化潜力很大。